Head-to-head · WeighScore
Found vs NowPatient
By GLP-1 ScorecardUpdated
Score comparison
Found has the higher recorded score — 83.5/100 to 65.5/100.
Found grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Found offers compounded, brand-name and oral GLP-1 routes, but their bills differ: compounded plans include medication and care, while branded medication and labs cost extra.
Before you choose
Before comparing the headline prices, the Found review and the NowPatient review set out what each semaglutide figure in the table below covers, including whether the medication is a brand-name product billed by a pharmacy. Brand-name and compounded prices are different products, so set like against like before treating either one as cheaper.
If neither one fits, Found vs NuDay Rx and No BS RX vs NowPatient compare each of them with another graded program, and the list of alternatives to Found ranks the programs closest to Found on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Found | NowPatient |
|---|---|---|
| WeighScore | 83.5/100 | 65.5/100 |
| Grade | B | C |
| Site position | #7 | #237 |
| Semaglutide | $149 first, then $269 every 28 days on the one-term cash compounded plan (labs extra; confirm selected terms) | Brand Wegovy $215.98-$395.98 per pen by strength, plus $75 shipping and import duties |
| Tirzepatide | $199 first, then $339 every 28 days on the one-term cash compounded plan (labs extra; confirm selected terms) | Brand Mounjaro $251.98-$476.98 per pen by strength, plus $75 shipping and import duties |
| Coverage | U.S. service with state, treatment and insurance restrictions; confirm your eligibility | Coverage not published |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Yes | Yes |
Strengths
- Current compounded offers include medication, membership and care, with separate semaglutide and tirzepatide price tables
- Branded injection and oral options are listed, subject to prescription, stock and patient-specific terms
- Insurance-track clinical visits and cash-pay care are distinguished in the public billing documents
- Terms name possible independent medical groups and describe check-ins and messaging
What to consider
- Cash compounded renewal rates differ by molecule and recur every 28 days, not a calendar month
- Longer-term advertised rates and upfront-payment wording do not settle the selected charge or supply
- Labs cost extra; insurance-track cost-sharing can add to the bill and does not reimburse compounded-medication fees
- Refund wording about three days and the first consultation conflicts; rejection of a preferred GLP-1 is not disqualification from all treatment
- The assigned compounder, actual treating practice and individual license status remain unresolved
- A brand or oral menu listing does not establish a specific available prescription, complete price or clinical equivalence
Strengths
- Free telehealth consultation — you only pay for the medication
- Brand-name Mounjaro, Wegovy injection, Wegovy oral tablet, and Saxenda all available
- One of the few platforms offering Wegovy in both injection and oral pill form
- No compounded options — every drug is FDA-approved brand-name
What to consider
- Cash-pay pricing tracks full brand list price (~$1,000–$1,350/mo)
- No compounded semaglutide or tirzepatide (usually the cheaper route)
- State availability determined during intake, not shown upfront
- Does not offer Foundayo (orforglipron)
Featured provider
Found
Factor scores not reassessed.Found scores 83.5/100 (B). Found offers compounded, brand-name and oral GLP-1 routes, but their bills differ: compounded plans include medication and care, while branded medication and labs cost extra.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.